Official Publications Nanobiotix

Equities

Market Closed - Euronext Paris Other stock markets 11:35:02 2024-05-21 am EDT			After market 12:15:53 pm
6.51 ^EUR	-0.91%		6.515	+0.08%

May. 14	Nanobiotix to Proceed to Phase 2 Trial of Lung Cancer Treatment	MT
May. 14	Nanobiotix Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating Nbtxr3 for Patients with Stage Three Lung Cancer	CI

Monthly statement on voting rights	22-06-29	CO
Monthly statement on voting rights	22-06-29	CO
Monthly statement on voting rights	22-05-30	CO
Monthly statement on voting rights	22-05-30	CO
1st quarter results	22-05-17	CO
1st quarter results	22-05-17	CO
Monthly statement on voting rights	22-04-29	CO
Monthly statement on voting rights	22-04-29	CO
Threshold crossings	22-04-13	CO
Monthly statement on voting rights	22-03-30	CO
Monthly statement on voting rights	22-03-30	CO
Monthly statement on voting rights	22-02-27	CO
Monthly statement on voting rights	22-01-30	CO